Impact of renin–angiotensin system blocker after aortic valve replacement—a systematic review and meta-analysis
Author(s) -
Li Zeng,
Junli Li,
Jinghan Yang,
Yanbiao Liao,
Mao Chen
Publication year - 2020
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-1155
Subject(s) - medicine , hazard ratio , meta analysis , confounding , ejection fraction , aortic valve replacement , valve replacement , cardiology , surgery , confidence interval , heart failure , stenosis
Data reporting the impact of renin-angiotensin system inhibitor (RASi) after aortic valve replacement (AVR) is controversy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom